Executive orders
1. Directing agencies to address vaccine and PPE supply shortfalls using all authorities including DPA;
2. Directing OSHA to publish worker safety guidelines;
3. Establishing a coronavirus testing board;
4. Directing government scientists to identify new treatments for COVID-19;
5. Directing HHS and CDC to provide clear guidance on safe school reopening;
6. Directing agencies to expand data collection and reporting capacity;
7. Establishing a health equity taskforce that focuses on racial/geographic health disparities; Dr. Marcella Nunez-Smith will be chair;
8. Enhancing the collection, sharing and analysis of covid data including metrics by race and ethnicity;
9. Require mask wearing on plane, trains and other forms of public transportation;
10. Bolster clinical care facilities and long term care facilities.
https://www.cbsnews.com/news/biden-national-covid-strategy-executive-orders/
Recent RNLX News
- Renalytix Reports Full Year Fiscal 2023 Results • GlobeNewswire Inc. • 09/28/2023 11:00:49 AM
- Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28 • GlobeNewswire Inc. • 09/25/2023 11:00:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:04:50 PM
- Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer • GlobeNewswire Inc. • 09/07/2023 11:00:27 AM
- Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd • GlobeNewswire Inc. • 08/03/2023 11:00:29 AM
- Renalytix Announces Middle East Distribution Agreement with Vector Pharma • GlobeNewswire Inc. • 07/21/2023 11:00:08 AM
- Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions • GlobeNewswire Inc. • 07/07/2023 11:00:47 AM
- Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors • GlobeNewswire Inc. • 07/03/2023 11:00:00 AM
- Renalytix Gets FDA De Novo Marketing Authorization for KidneyIntelX.dkd • Dow Jones News • 06/29/2023 10:58:00 PM
- FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease • GlobeNewswire Inc. • 06/29/2023 10:01:17 PM
- KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences • GlobeNewswire Inc. • 06/15/2023 11:00:00 AM
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023 • GlobeNewswire Inc. • 06/09/2023 11:00:53 AM
- Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9 • GlobeNewswire Inc. • 06/05/2023 11:00:10 AM
- Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes • GlobeNewswire Inc. • 05/25/2023 11:00:00 AM
- New Published Real-World Evidence Shows KidneyIntelX™ Utility • GlobeNewswire Inc. • 04/19/2023 11:00:28 AM
- Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting • GlobeNewswire Inc. • 04/12/2023 11:00:26 AM
- Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 03/30/2023 11:00:15 AM
- Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30 • GlobeNewswire Inc. • 03/22/2023 11:00:27 AM
- Renalytix Shares Fall on Delay to FDA Marketing Authorization Decision on KidneyIntelX • Dow Jones News • 03/21/2023 09:18:00 AM
- Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 02/09/2023 12:00:12 PM
- Renalytix announces a c.$20.3 million private placement • GlobeNewswire Inc. • 02/08/2023 12:00:49 PM
- Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States • GlobeNewswire Inc. • 01/26/2023 12:00:00 PM
- Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems • GlobeNewswire Inc. • 01/09/2023 12:00:00 PM
- BTIG Remains a Buy on Renalytix AI (RNLX) • TipRanks • 12/03/2022 03:05:22 AM
- H.C. Wainwright Sticks to Their Buy Rating for Renalytix AI (RNLX) • TipRanks • 12/02/2022 05:05:08 PM
FEATURED Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath • Oct 3, 2023 8:50 AM
Strategic Joint Venture Signed by Santo Mining Corp. and Planta Vida S.A.S. • SANP • Oct 3, 2023 3:00 PM
Good Gaming, Inc. Announces Galactic Acres™ as Its First Mobile Game Integrated with Web3 Technology • GMER • Oct 3, 2023 8:30 AM
HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • HLYK • Oct 3, 2023 8:00 AM
Nate's Food Co Successfully Completes Cancellation of 1 Billion Common Shares, Paving the Way for a Bright Future • NHMD • Oct 3, 2023 8:00 AM
Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • BLEG • Oct 3, 2023 8:00 AM